Mt. Valenti et al., DIFFERENTIATION, PROLIFERATION AND APOPTOSIS LEVELS IN HUMAN LEIOMYOMA AND LEIOMYOSARCOMA, Journal of cancer research and clinical oncology, 124(2), 1998, pp. 93-105
A comparative analysis of the differentiation pattern, the proliferati
ve behaviour, and the level of apoptosis between human benign and mali
gnant neoplasms of smooth-muscle (SM) tissue is lacking. The clinical,
histopathological, immunochemical, and immunocytochemical features of
leiomyomas (LM) and leiomyosarcomas (LMS) were investigated by a pane
l of monoclonal antibodies specific for some differentiation markers o
f SM tissue (SM myosin and alpha-actin, desmin, and SM22) and for mark
ers of non-muscle tissue (vimentin and non-muscle myosin). Proliferati
ng normal and neoplastic cells were identified by proliferating-cell n
uclear antigen (PCNA)/Ki67 immunostainings and the apoptotic cells wer
e revealed by means of the terminal-deoxynucleolidyltransferase-mediat
ed dUTP nick-end labelling technique. Cel electrophoresis and Western
blotting, performed with anti-(SM1/SM2 myosin isoform) antibody, indic
ated quantitative differences between LMS and LM, which mirrored highe
r positive to negative nuclear ratios for PCNA, Ki67 and apoptosis in
malignant as opposed to benign neoplasms. With LM, however, a similar
SM1 to SM2 ratio could be associated with different proliferation leve
ls. Uterine, gastric and intestinal LMS displayed specific patterns of
SM1/SM2 and/or non-muscle myosin expression that were not paralled by
different levels of proliferation/apoptosis. While the level of PCNA/
Ki67 correlated with the level of apoptosis in normal SM tissues and L
M, that of LMS did not. In vivo at the cellular level, LM and uterine
LMS displayed a near-uniform SM tissue differentiation, whereas the ot
her LMS displayed a lesser or a heterogeneous immunoreactivity. In vit
ro, cultured LMS cells showed a limited and peculiar expression of SM
myosin. In conclusion, there is no reciprocal relationship between deg
ree of differentiation and the level of proliferation, as exemplified
by the finding that the less differentiated intestinal LMS displays th
e lowest proliferative behaviour and that the relatively more differen
tiated gastric LMS/metastasis is more proliferative.